Dezhan Health (000813): Temporary Suspension Of Cooperative Investment In Hong Kong Emission Rights Exchange

German exhibition health (000813. SZ) issued an announcement on April 21, 2021, The company's wholly-owned subsidiary, Shenzhen degar Health Industry Investment Co., Ltd. (hereinafter referred to as "degar health") and global carbon assets Co., Ltd. (hereinafter referred to as "carbon asset company") and Hong Kong emission rights exchange Co., Ltd. (hereinafter referred to as "emission right exchange"), signed the "Shenzhen degar Health Industry Investment Co., Ltd. and global carbon assets Co., Ltd. on emissions trading in Hong Kong The letter of intent for investment of the Company Limited (hereinafter referred to as the "letter of intent") stipulates that both parties shall establish a cooperative relationship and agree to take measures including but not limited to the acquisition or capital increase of emission trading by Degas health to achieve the purpose of holding shares, and any other possible cooperation modes agreed by all parties.

As of the date of this announcement, the cooperation period of the above letter of intent and its supplementary agreement has expired, and the relevant due diligence and transaction arrangements are still in progress. However, in view of the changes in the controlling shareholders of the company, Xinjiang Kaidi Investment Co., Ltd. has become the new controlling shareholder of the company, The state owned assets supervision and Administration Committee of the people's Government of Xinjiang Uygur Autonomous Region has become the new actual controller of the company, and the company is in the process of a new board of directors election. Therefore, according to the relevant arrangements during the transitional period of the company, the above-mentioned cooperation matters will be suspended temporarily, and subsequent arrangements for relevant cooperation will be decided after the new board of directors of the company is formed.